Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Saniona AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Saniona AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Saniona AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Saniona AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Saniona AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Saniona AB, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Saniona Acquires ACR325 and ACR343 Drugs from NeuroSearch 11
Saniona Acquires Assets from NeuroSearch 12
Saniona Acquires Technical Platforms from NeuroSearch 13
Aniona Acquires Portfolio of Preclinical Assets from NeuroSearch 14
Partnerships 15
Boehringer Ingelheim Enters into Research Agreement with Saniona 15
Saniona Enters into Agreement with Productos Medix 16
Saniona Enters into Agreement with Syngene 17
Saniona Extends R&D Agreement with Ataxion 18
Equity Offering 19
Initiator Pharma to Raise USD2.4 Million in Rights Offering of Units 19
Scandion Oncology Raises USD0.3 Million in Private Placement of Shares 20
Saniona Raises USD4 Million in Private Placement of Shares 21
Scandion Oncology Spins-Off from Saniona 22
Initiator Pharma Raises USD2.3 Million in Rights Offering of Shares 23
Initiator Pharma Spins Out from Saniona 24
Saniona Completes IPO For US$2.6 Million 25
Debt Offering 26
Saniona to Raise USD8.7 Million in Private Placement of Bonds 26
Asset Transactions 27
Ataxion Acquires Ataxia Program from Saniona 27
Saniona AB – Key Competitors 28
Saniona AB – Key Employees 29
Saniona AB – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Financial Announcements 31
Aug 22, 2018: Saniona publishes its interim report for the second quarter 2018 31
May 24, 2018: Saniona publishes its interim report for the first quarter 2018 32
Feb 21, 2018: Saniona publishes its year-end report for 2017 33
Nov 15, 2017: Saniona publishes its interim report for the third quarter 2017 34
Aug 23, 2017: Saniona publishes its interim report for the second quarter 2017 35
Feb 21, 2017: Saniona publishes year-end report for 2016 36
Corporate Communications 37
Dec 22, 2017: Saniona: The Nomination Committee of Saniona Proposes Election of Two Additional Members of the Board of Directors 37
May 31, 2017: Saniona approved for listing on Nasdaq Stockholm’s main market 39
Product News 40
10/03/2017: Saniona obtains Research Milestone from The Michael J. Fox Foundation for Parkinsons Research of about USD 119,487 40
04/20/2017: Saniona: Saniona obtains research milestone from The Michael J. Fox Foundation for Parkinson’s Research 41
Clinical Trials 42
Dec 04, 2017: Saniona Selects Preclinical Candidate in GABAA a2/a3 Program for Neuropathic Pain and Chronic Itching 42
Sep 18, 2017: Saniona reports encouraging start for tesofensine Phase 3 study 43
Aug 21, 2017: Saniona’s Partner, Medix, Initiates Phase 3 Study for tesofensine in Obesity 44
Apr 12, 2017: Saniona’s partner, Medix, obtains approval to initiate Phase 3 study in obesity 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46
Saniona AB, Pharmaceuticals & Healthcare, Key Facts 2
Saniona AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Saniona AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Saniona AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Saniona AB, Deals By Therapy Area, 2012 to YTD 2018 9
Saniona AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Saniona Acquires ACR325 and ACR343 Drugs from NeuroSearch 11
Saniona Acquires Assets from NeuroSearch 12
Saniona Acquires Technical Platforms from NeuroSearch 13
Aniona Acquires Portfolio of Preclinical Assets from NeuroSearch 14
Boehringer Ingelheim Enters into Research Agreement with Saniona 15
Saniona Enters into Agreement with Productos Medix 16
Saniona Enters into Agreement with Syngene 17
Saniona Extends R&D Agreement with Ataxion 18
Initiator Pharma to Raise USD2.4 Million in Rights Offering of Units 19
Scandion Oncology Raises USD0.3 Million in Private Placement of Shares 20
Saniona Raises USD4 Million in Private Placement of Shares 21
Scandion Oncology Spins-Off from Saniona 22
Initiator Pharma Raises USD2.3 Million in Rights Offering of Shares 23
Initiator Pharma Spins Out from Saniona 24
Saniona Completes IPO For US$2.6 Million 25
Saniona to Raise USD8.7 Million in Private Placement of Bonds 26
Ataxion Acquires Ataxia Program from Saniona 27
Saniona AB, Key Competitors 28
Saniona AB, Key Employees 29
Saniona AB, Subsidiaries 30
List of Figures
Saniona AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Saniona AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Saniona AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Saniona AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Saniona AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Saniona AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Saniona AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Saniona AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9